Pricing Log in Create free account

aTyr Pharma, Inc. (ATYR) vs Vaxxinity, Inc. (VAXX)

aTyr Pharma, Inc. and Vaxxinity, Inc. are both Biotechnology companies. aTyr Pharma, Inc. and Vaxxinity, Inc. are of similar size ($15.5M and $14.8M). Across the 11 metrics below, Vaxxinity, Inc. leads on 6 and aTyr Pharma, Inc. on 5.

Valuation

Metric ATYR VAXX Biotechnology median
P/E n/m n/m 10.60
P/S 1.38 n/m 9.40
P/B 0.32 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.61 0.30 0.66
EV/Sales (3.49) (94.20) 9.02
Earnings yield (397.17%) 0.00% (32.88%)
Free cash flow yield (355.97%) 0.00% (23.13%)

Profitability

Metric ATYR VAXX Biotechnology median
Gross margin 1.72% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (98.67%) (150.65%) (51.96%)
Return on assets (70.97%) (75.55%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ATYR VAXX Biotechnology median
Revenue growth (TTM) 6.78% — 6.76%
EPS growth (last fiscal year) 7.54% 25.00% 29.88%
Revenue growth, 5-year CAGR (14.75%) — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ATYR VAXX Biotechnology median
Debt to equity 0.00 0.99 0.00
Current ratio 5.12 1.89 4.97
Net debt to EBITDA 1.01 0.30 1.01

Dividend

Metric ATYR VAXX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ATYR VAXX Biotechnology median
Market cap 14.78m 15.47m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack